MERAKRIS THERAPEUTICS ANNOUNCES COMPLETION OF TYPE C MEETING WITH FDA – ALIGNMENT ON MTX-001 BIOLOGIC DRUG DEVELOPMENT PATHWAY

Reuters · 1d ago

Please log in to view news